Julius Clinical invites you to their event

Novel developments in the GUT-PANCREAS-LIVER axis for NASH treatment

About this event

NASH Webinar Series

Webinar 7 - Novel developments in the GUT-PANCREAS-LIVER axis for NASH treatment

During this webinar, Amalia Gastaldelli will talk about the impact of GLP-1 and insulin secretion and clearance ho hepatic metabolism (and NASH). Amalia will also dicuss the new twincretins and their effects on hepatic fat, lipid and glucose metabolism (that are also mediated by the pancreatic hormones insulin and glucagon).

Speaker: Amalia Gastaldelli

Host: Prof. Manuel Castro Cabezas

Co-host: Prof. Christophe Moreno

Audience: Clinicians, researchers, pharmaceutical industry workers, public health workers

----------------------------------------------------------------------------------------

NASH Webinar Series

This webinar is the 7th webinar of the NASH webinar series, each focusing on recent developments or publications on nonalcoholic steatohepatitis (NASH). The topics and publications are selected by KOLs of NASH Clinical based on relevant ground-breaking NASH research in a high-impact journal. During these webinars we offer you the opportunity to interact with original authors and experts in the NASH field.

Hosted by

  • Guest speaker
    CM G
    Christophe Moreno

  • Guest speaker
    MC G
    Manuel Castro Cabezas

  • Guest speaker
    AG G
    Amalia Gastaldelli

  • Guest speaker
    MC G
    Martin Czakon

Julius Clinical

The Academic CRO

Julius Clinical is the Academic Contract Research Organisation (CRO) that manages global clinical drug trials that will have a major impact on medicine and make a real difference to people’s lives around the world.